CDT Partners With QIMA Life Sciences to Evaluate Tapinarof Combinations
CDT Equity Inc. (NASDAQ:CDT) announced a partnership with QIMA Life Sciences to explore novel tapinarof combinations for psoriasis and vitiligo.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.